Produkty 6519-27-3

CAS 6519-27-3 występuje w naszej ofercie pod nazwami: Methyl 2-((12Br)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo(2,3-a)quinolizin-2-yl)-3-hydroxypropanoate, (16R)-E-Isositsirikine. Oferty producentów: Biosynth, MedChemExpress. Dostępne opakowania: 10mg, 5mg, 25mg, 50mg, Get quote.

Methyl 2-((12Br)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo(2,3-a)quinolizin-2-yl)-3-hydroxypropanoate
Biosynth
  • opakowanie: 10mg, 5mg, 25mg, 50mg
  • Warianty: 4
Zobacz produkt
(16R)-E-Isositsirikine
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

Methyl (2R)-2-[(2R,3E,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate (CAS 6519-27-3) to związek chemiczny o wzorze sumarycznym C21H26N2O3 i masie molowej 354.4 g/mol. Nazwa systematyczna IUPAC: methyl (2R)-2-[(2R,3E,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate. InChIKey: RGXKJLTVROJBKZ-LZNZQLKFSA-N.

Dane identyfikacyjne
Wzór sumarycznyC21H26N2O3
Masa molowa354.4 g/mol
Nazwa IUPACmethyl (2R)-2-[(2R,3E,12bS)-3-ethylidene-2,4,6,7,12,12b-hexahydro-1H-indolo[2,3-a]quinolizin-2-yl]-3-hydroxypropanoate
InChIKeyRGXKJLTVROJBKZ-LZNZQLKFSA-N
SMILESC/C=C\1/CN2CCC3=C([C@@H]2C[C@@H]1[C@H](CO)C(=O)OC)NC4=CC=CC=C34

Dane obliczone przez PubChem (NCBI)

Synonimy: Isositsirikine, 16-epi-Isositsirikine, (16R)-E-Isositsirikine, 16R,19E-isositsirikine, (16R,19E)-isositsirikine, 16(R)-E-isositsirikine, orb1683869, 16R-19,20-E-isositsirikine, 16(R)-19,20-E-isositsirikine
Izomery (ten sam wzór sumaryczny)
benzyl N-[1-(butylamino)-1-oxo-3-phenylpropan-2-yl]carbamate C21H26N2O3
6-[3-(1-acetylpiperidin-4-yl)propanoyl]-1-azatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-11-one C21H26N2O3
benzyl N-[1-(tert-butylamino)-1-oxo-3-phenylpropan-2-yl]carbamate C21H26N2O3
benzyl N-[(1S)-2-[(3S)-3-hydroxypyrrolidin-1-yl]-1-phenylethyl]-N-methylcarbamate C21H26N2O3
methyl (15R,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate C21H26N2O3
methyl 15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate C21H26N2O3
methyl (15R,17S,19R)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate C21H26N2O3
methyl (15S,17S,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate C21H26N2O3
methyl (1S,15R,18S,19S,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate C21H26N2O3
methyl (1S,15R,18R,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate C21H26N2O3
methyl (15S,17R,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate C21H26N2O3
methyl (15R,17R,19S)-15-ethyl-17-hydroxy-1,11-diazapentacyclo[9.6.2.02,7.08,18.015,19]nonadeca-2,4,6,8(18)-tetraene-17-carboxylate C21H26N2O3